Clinical Trial Update: Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD) [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update evaluating Extracorporeal Photopheresis using Theraflex ECP for patients with refractory chronic graft-ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Theraflex ECP

Snippet

Sponsor: Jules Bordet Institute | Conditions: Refractory Chronic Graft Versus Host Disease (cGVHD) | Phase 2 | Status: UNKNOWN